WuXi XDC Cayman, Inc. (HK:2268) has released an update.
WuXi XDC Cayman Inc. has announced a delay in the despatch of a circular originally set for on or before September 16, 2024, detailing the Antibodies Master Services Agreement and revised annual caps. The new despatch date is extended to a deadline of on or before September 30, 2024, due to the need for additional time to prepare and finalize necessary information. Shareholders are advised to anticipate the circular’s arrival by the revised date.
For further insights into HK:2268 stock, check out TipRanks’ Stock Analysis page.